RPID
Rapid Micro Biosystems, Inc.
Price Chart
Latest Quote
$1.71
+0.03 (+1.79%)
Current Price
| Previous Close | $1.68 |
| Open | $1.70 |
| Day High | $1.73 |
| Day Low | $1.67 |
| Volume | 118,656 |
Stock Information
| Shares Outstanding | 45.32M |
| Total Debt | $23.71M |
| Cash Equivalents | $23.72M |
| Revenue | $34.38M |
| Net Income | $-50.13M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $85.20M |
| EPS (TTM) | $-1.10 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $78.94M |
| Sales | $34.38M |
| Income | $-50.13M |
| Book/sh | $0.45 |
| Cash/sh | $0.52 |
| Employees | 171 |
Financial Ratios
| Quick Ratio | 1.58 |
| Current Ratio | 2.58 |
| Debt/Eq | 116.24 |
Returns & Margins
| ROA | -41.94% |
| ROE | -116.74% |
| Gross Margin | 2.95% |
| Operating Margin | -173.11% |
| Profit Margin | -145.81% |
Ownership
| Insider Ownership | 10.26% |
| Institutional Ownership | 54.14% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -2.16 |
| P/S | 2.48 |
| P/B | 3.83 |
Analyst Data
| Recommendation | none |
| Target Price | $6.67 |
Technical Indicators
| SMA20 | $1.91 |
| SMA50 | $2.15 |
| SMA200 | $3.12 |
| RSI | 23.21 |
| ATR | 0.1169 |
| Shares Float | 30.11M |
| Short Float | 2.44% |
| Short Ratio | 4.82 |
| Volatility | 1.46 |
| Rel Volume | 0.86 |
Performance History
| Week | -9.04% |
| Month | -13.64% |
| Quarter | -31.60% |
| 6 Months | -51.42% |
| YTD | -45.54% |
| Year | -50.72% |
| 3 Years | +55.45% |
| 10 Years | -92.01% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $1.71 | 118,700 |
| 2026-06-17 | $1.68 | 276,700 |
| 2026-06-16 | $1.66 | 120,000 |
| 2026-06-15 | $1.72 | 252,300 |
| 2026-06-12 | $1.76 | 144,700 |
| 2026-06-11 | $1.88 | 46,100 |
| 2026-06-10 | $1.83 | 132,600 |
| 2026-06-09 | $1.88 | 144,200 |
| 2026-06-08 | $1.99 | 91,900 |
| 2026-06-05 | $1.99 | 177,200 |
| 2026-06-04 | $1.99 | 165,200 |
| 2026-06-03 | $1.96 | 60,700 |
| 2026-06-02 | $1.96 | 117,800 |
| 2026-06-01 | $1.97 | 80,200 |
| 2026-05-29 | $2.01 | 81,200 |
| 2026-05-28 | $2.02 | 175,300 |
| 2026-05-27 | $1.96 | 202,400 |
| 2026-05-26 | $2.01 | 125,200 |
| 2026-05-22 | $2.05 | 65,900 |
| 2026-05-21 | $2.07 | 170,900 |
| 2026-05-20 | $2.01 | 462,400 |
| 2026-05-19 | $1.98 | 234,400 |
About Rapid Micro Biosystems, Inc.
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the antiquated, manual microbial quality control (MQC), testing workflows for therapeutic modalities, such as biologics and cell and gene therapies, vaccines, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
đ° Latest News
Rapid Micro Biosystems Inc (RPID) Q1 2026 Earnings Call Highlights: Strong Revenue Growth ...
GuruFocus.com âĸ 2026-05-14T05:02:04ZRapid Micro Biosystems Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-14T04:12:30Z
Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates
Zacks âĸ 2026-05-13T22:10:03Z
ClearPoint Neuro, Inc. (CLPT) Reports Q1 Loss, Lags Revenue Estimates
Zacks âĸ 2026-05-13T21:35:02Z
Rapid Micro Biosystems Q1 2026 Earnings Call: Complete Transcript
Benzinga âĸ 2026-05-13T21:31:43Z
Pioneer Power Solutions And 2 Other Penny Stocks Worth Watching
Simply Wall St. âĸ 2026-04-28T18:05:26Z
White Brook Capital Shared Insights on Rapid Micro Biosystems (RPID)
Insider Monkey âĸ 2026-04-23T13:14:28Z
What Makes Rapid Micro Biosystems (RPID) a New Buy Stock
Zacks âĸ 2026-04-14T16:00:06Z
Rapid Micro Biosystems Eyes $37M-$41M 2026 Revenue as Growth Direct Day Draws Record Crowd
MarketBeat âĸ 2026-03-22T03:06:43Z
Rapid Micro Biosystems Inc (RPID) Q4 2025 Earnings Call Highlights: Record Revenue Growth Amid ...
GuruFocus.com âĸ 2026-03-12T19:04:02Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $32,540,000 | $28,160,000 | $28,004,000 | $25,673,000 |
| Cost Of Revenue | $32,540,000 | $28,160,000 | $28,004,000 | $25,673,000 |
| Total Revenue | $33,587,000 | $28,051,000 | $22,519,000 | $17,133,000 |
| Operating Revenue | $33,587,000 | $28,051,000 | $22,519,000 | $17,133,000 |
| Expenses | ||||
| Interest Expense | $1,090,000 | $40,000 | - | - |
| Total Expenses | $80,979,000 | $77,970,000 | $79,082,000 | $80,352,000 |
| Other Income Expense | $-110,000 | $-112,000 | $-83,000 | $59,000 |
| Other Non Operating Income Expenses | $-110,000 | $-112,000 | $-83,000 | $59,000 |
| Net Non Operating Interest Income Expense | $419,000 | $3,164,000 | $4,210,000 | $1,778,000 |
| Interest Expense Non Operating | $1,090,000 | $40,000 | - | - |
| Operating Expense | $48,439,000 | $49,810,000 | $51,078,000 | $54,679,000 |
| Selling And Marketing Expense | $12,082,000 | $13,266,000 | $13,322,000 | $14,994,000 |
| General And Administrative Expense | $22,754,000 | $21,947,000 | $24,936,000 | $26,819,000 |
| Total Other Finance Cost | - | - | - | $-1,778,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-47,123,000 | $-46,889,000 | $-52,467,000 | $-60,806,000 |
| Net Interest Income | $419,000 | $3,164,000 | $4,210,000 | $1,778,000 |
| Interest Income | $1,509,000 | $3,204,000 | $4,210,000 | $1,778,000 |
| Normalized Income | $-47,123,000 | $-46,889,000 | $-52,467,000 | $-60,806,000 |
| Net Income From Continuing And Discontinued Operation | $-47,123,000 | $-46,889,000 | $-52,467,000 | $-60,806,000 |
| Total Operating Income As Reported | $-47,392,000 | $-49,919,000 | $-56,563,000 | $-63,219,000 |
| Net Income Common Stockholders | $-47,123,000 | $-46,889,000 | $-52,467,000 | $-60,806,000 |
| Net Income | $-47,123,000 | $-46,889,000 | $-52,467,000 | $-60,806,000 |
| Net Income Including Noncontrolling Interests | $-47,123,000 | $-46,889,000 | $-52,467,000 | $-60,806,000 |
| Net Income Continuous Operations | $-47,123,000 | $-46,889,000 | $-52,467,000 | $-60,806,000 |
| Pretax Income | $-47,083,000 | $-46,867,000 | $-52,436,000 | $-61,382,000 |
| Interest Income Non Operating | $1,509,000 | $3,204,000 | $4,210,000 | $1,778,000 |
| Operating Income | $-47,392,000 | $-49,919,000 | $-56,563,000 | $-63,219,000 |
| Gross Profit | $1,047,000 | $-109,000 | $-5,485,000 | $-8,540,000 |
| Special Income Charges | - | - | - | $0 |
| Per Share | ||||
| Diluted EPS | $-1.05 | $-1.08 | $-1.22 | $-1.43 |
| Basic EPS | $-1.05 | $-1.08 | $-1.22 | $-1.43 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-42,741,000 | $-43,465,000 | $-53,458,000 | $-60,382,000 |
| Reconciled Depreciation | $3,252,000 | $3,362,000 | $3,105,000 | $2,837,000 |
| EBITDA (Bullshit earnings) | $-42,741,000 | $-43,465,000 | $-53,458,000 | $-60,382,000 |
| EBIT | $-45,993,000 | $-46,827,000 | $-56,563,000 | $-63,219,000 |
| Diluted Average Shares | $44,679,341 | $43,575,705 | $43,024,039 | $42,454,403 |
| Basic Average Shares | $44,679,341 | $43,575,705 | $43,024,039 | $42,454,403 |
| Diluted NI Availto Com Stockholders | $-47,123,000 | $-46,889,000 | $-52,467,000 | $-60,806,000 |
| Tax Provision | $40,000 | $22,000 | $31,000 | $-576,000 |
| Research And Development | $13,603,000 | $14,597,000 | $12,820,000 | $12,866,000 |
| Selling General And Administration | $34,836,000 | $35,213,000 | $38,258,000 | $41,813,000 |
| Other Gand A | $22,754,000 | $21,947,000 | $24,936,000 | $26,819,000 |
| Total Unusual Items | - | - | - | $0 |
| Total Unusual Items Excluding Goodwill | - | - | - | $0 |
| Otherunder Preferred Stock Dividend | - | - | - | $0 |
| Preferred Stock Dividends | - | - | - | - |
| Other Special Charges | - | - | - | - |
| Gain On Sale Of Security | - | - | - | - |
Fetched: 2026-06-17
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $33,206,000 | $75,352,000 | $117,989,000 | $164,169,000 |
| Total Assets | $74,852,000 | $98,169,000 | $143,452,000 | $190,650,000 |
| Total Non Current Assets | $13,684,000 | $17,252,000 | $23,037,000 | $52,074,000 |
| Other Non Current Assets | $603,000 | $896,000 | $1,054,000 | $1,403,000 |
| Current Assets | $61,168,000 | $80,917,000 | $120,415,000 | $138,576,000 |
| Other Current Assets | $854,000 | $843,000 | $577,000 | $705,000 |
| Prepaid Assets | $1,147,000 | $1,617,000 | $2,241,000 | $2,555,000 |
| Inventory | $17,593,000 | $20,200,000 | $19,961,000 | $21,187,000 |
| Receivables | $3,278,000 | $7,525,000 | $5,583,000 | $5,481,000 |
| Other Receivables | $144,000 | $6,000 | $51,000 | $112,000 |
| Accounts Receivable | $3,134,000 | $7,519,000 | $5,532,000 | $5,369,000 |
| Cash Cash Equivalents And Short Term Investments | $38,296,000 | $50,732,000 | $92,053,000 | $108,648,000 |
| Cash And Cash Equivalents | $20,030,000 | $16,911,000 | $24,285,000 | $27,064,000 |
| Investmentin Financial Assets | - | - | $2,911,000 | $29,790,000 |
| Debt | ||||
| Total Debt | $23,874,000 | $6,168,000 | $7,346,000 | $7,968,000 |
| Long Term Debt And Capital Lease Obligation | $22,576,000 | $4,954,000 | $6,214,000 | $7,202,000 |
| Long Term Debt | $18,902,000 | - | - | - |
| Current Debt And Capital Lease Obligation | $1,298,000 | $1,214,000 | $1,132,000 | $766,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $41,646,000 | $22,817,000 | $25,463,000 | $26,481,000 |
| Total Non Current Liabilities Net Minority Interest | $23,159,000 | $5,252,000 | $6,477,000 | $7,431,000 |
| Other Non Current Liabilities | $397,000 | $298,000 | $263,000 | $229,000 |
| Derivative Product Liabilities | $186,000 | $0 | - | - |
| Current Liabilities | $18,487,000 | $17,565,000 | $18,986,000 | $19,050,000 |
| Other Current Liabilities | $26,000 | $152,000 | $141,000 | $520,000 |
| Current Deferred Liabilities | $4,734,000 | $6,599,000 | $5,974,000 | $4,706,000 |
| Payables And Accrued Expenses | $7,633,000 | $5,136,000 | $6,931,000 | $9,841,000 |
| Payables | $4,408,000 | $2,770,000 | $2,225,000 | $5,757,000 |
| Total Tax Payable | $269,000 | $235,000 | $252,000 | $329,000 |
| Accounts Payable | $4,139,000 | $2,535,000 | $1,973,000 | $5,428,000 |
| Non Current Deferred Liabilities | - | - | - | $0 |
| Interest Payable | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $33,206,000 | $75,352,000 | $117,989,000 | $164,169,000 |
| Total Equity Gross Minority Interest | $33,206,000 | $75,352,000 | $117,989,000 | $164,169,000 |
| Stockholders Equity | $33,206,000 | $75,352,000 | $117,989,000 | $164,169,000 |
| Gains Losses Not Affecting Retained Earnings | $11,000 | $39,000 | $-101,000 | $-1,109,000 |
| Other Equity Adjustments | $11,000 | $39,000 | $-101,000 | - |
| Retained Earnings | $-522,397,000 | $-475,274,000 | $-428,385,000 | $-375,918,000 |
| Preferred Securities Outside Stock Equity | - | - | - | - |
| Other | ||||
| Ordinary Shares Number | $44,470,475 | $43,038,771 | $42,409,438 | $42,092,184 |
| Share Issued | $44,470,475 | $43,038,771 | $42,409,438 | $42,092,184 |
| Tangible Book Value | $33,206,000 | $75,352,000 | $117,989,000 | $164,169,000 |
| Invested Capital | $52,108,000 | $75,352,000 | $117,989,000 | $164,169,000 |
| Working Capital | $42,681,000 | $63,352,000 | $101,429,000 | $119,526,000 |
| Capital Lease Obligations | $4,972,000 | $6,168,000 | $7,346,000 | $7,968,000 |
| Total Capitalization | $52,108,000 | $75,352,000 | $117,989,000 | $164,169,000 |
| Additional Paid In Capital | $555,147,000 | $550,157,000 | $546,051,000 | $540,775,000 |
| Capital Stock | $445,000 | $430,000 | $424,000 | $421,000 |
| Common Stock | $445,000 | $430,000 | $424,000 | $421,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $3,674,000 | $4,954,000 | $6,214,000 | $7,202,000 |
| Current Deferred Revenue | $4,734,000 | $6,599,000 | $5,974,000 | $4,706,000 |
| Current Capital Lease Obligation | $1,298,000 | $1,214,000 | $1,132,000 | $766,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $4,796,000 | $4,464,000 | $4,808,000 | $3,217,000 |
| Current Accrued Expenses | $3,225,000 | $2,366,000 | $4,706,000 | $4,084,000 |
| Net PPE | $13,081,000 | $16,356,000 | $19,072,000 | $20,881,000 |
| Accumulated Depreciation | $-19,296,000 | $-16,521,000 | $-14,310,000 | $-11,802,000 |
| Gross PPE | $32,377,000 | $32,877,000 | $33,382,000 | $32,683,000 |
| Leases | $9,447,000 | $9,178,000 | $8,551,000 | $8,260,000 |
| Construction In Progress | $872,000 | $1,594,000 | $2,292,000 | $1,712,000 |
| Other Properties | $19,465,000 | $19,620,000 | $19,990,000 | $20,471,000 |
| Machinery Furniture Equipment | $2,593,000 | $2,485,000 | $2,549,000 | $2,240,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $4,879,000 | $9,268,000 | $6,938,000 | $4,574,000 |
| Work In Process | $884,000 | $372,000 | $150,000 | $1,599,000 |
| Raw Materials | $11,830,000 | $10,560,000 | $12,873,000 | $15,014,000 |
| Other Short Term Investments | $18,266,000 | $33,821,000 | $67,768,000 | $81,584,000 |
| Investments And Advances | - | $0 | $2,911,000 | $29,790,000 |
Fetched: 2026-06-17
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-31,912,000 | $-45,518,000 | $-46,926,000 | $-65,287,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-31,062,000 | $-44,153,000 | $-45,081,000 | $-58,547,000 |
| Cash Flow From Continuing Operating Activities | $-31,062,000 | $-44,153,000 | $-45,081,000 | $-58,547,000 |
| Operating Gains Losses | - | - | - | $28,000 |
| Investing Activities | ||||
| Capital Expenditure | $-850,000 | $-1,365,000 | $-1,845,000 | $-6,740,000 |
| Investing Cash Flow | $14,329,000 | $36,657,000 | $42,153,000 | $-93,469,000 |
| Cash Flow From Continuing Investing Activities | $14,329,000 | $36,657,000 | $42,153,000 | $-93,469,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $445,000 | $0 | - | $0 |
| Financing Cash Flow | $19,771,000 | $203,000 | $149,000 | $693,000 |
| Cash Flow From Continuing Financing Activities | $19,771,000 | $203,000 | $149,000 | $693,000 |
| Net Other Financing Charges | $-1,297,000 | - | - | - |
| Net Common Stock Issuance | $445,000 | $0 | - | $0 |
| Common Stock Issuance | $445,000 | $0 | - | $0 |
| Net Preferred Stock Issuance | - | - | - | $0 |
| Preferred Stock Issuance | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $-30,000 | $-35,000 | $-37,000 | $-33,000 |
| Issuance Of Debt | $20,000,000 | $0 | - | - |
| Interest Paid Supplemental Data | $770,000 | $40,000 | $38,000 | $42,000 |
| End Cash Position | $20,314,000 | $17,276,000 | $24,569,000 | $27,348,000 |
| Beginning Cash Position | $17,276,000 | $24,569,000 | $27,348,000 | $178,671,000 |
| Changes In Cash | $3,038,000 | $-7,293,000 | $-2,779,000 | $-151,323,000 |
| Proceeds From Stock Option Exercised | $653,000 | $238,000 | $186,000 | $726,000 |
| Net Issuance Payments Of Debt | $19,970,000 | $-35,000 | $-37,000 | $-33,000 |
| Net Long Term Debt Issuance | $19,970,000 | $-35,000 | $-37,000 | $-33,000 |
| Long Term Debt Payments | $-30,000 | $-35,000 | $-37,000 | $-33,000 |
| Long Term Debt Issuance | $20,000,000 | $0 | - | - |
| Net Investment Purchase And Sale | $15,179,000 | $38,022,000 | $43,998,000 | $-86,729,000 |
| Sale Of Investment | $42,255,000 | $73,057,000 | $106,490,000 | $92,500,000 |
| Purchase Of Investment | $-27,076,000 | $-35,035,000 | $-62,492,000 | $-179,229,000 |
| Net PPE Purchase And Sale | $-850,000 | $-1,365,000 | $-1,845,000 | $-6,740,000 |
| Purchase Of PPE | $-850,000 | $-1,365,000 | $-1,845,000 | $-6,740,000 |
| Change In Working Capital | $6,064,000 | $-4,771,000 | $555,000 | $-5,325,000 |
| Change In Other Working Capital | $-1,864,000 | $626,000 | $1,269,000 | $1,401,000 |
| Change In Other Current Liabilities | $64,000 | $0 | - | $0 |
| Change In Other Current Assets | $64,000 | $-150,000 | $5,000 | $179,000 |
| Change In Payables And Accrued Expense | $1,628,000 | $-3,328,000 | $-2,021,000 | $-1,276,000 |
| Change In Accrued Expense | $28,000 | $-3,890,000 | $1,434,000 | $-2,760,000 |
| Change In Payable | $1,600,000 | $562,000 | $-3,455,000 | $1,484,000 |
| Change In Account Payable | $1,600,000 | $562,000 | $-3,455,000 | $1,484,000 |
| Change In Prepaid Assets | $320,000 | $403,000 | $272,000 | $578,000 |
| Change In Inventory | $1,465,000 | $-335,000 | $1,193,000 | $-5,843,000 |
| Change In Receivables | $4,387,000 | $-1,987,000 | $-163,000 | $-364,000 |
| Changes In Account Receivables | $4,387,000 | $-1,987,000 | $-163,000 | $-364,000 |
| Other Non Cash Items | $1,218,000 | $1,200,000 | $1,237,000 | $1,036,000 |
| Stock Based Compensation | $4,033,000 | $3,874,000 | $4,750,000 | $4,019,000 |
| Provisionand Write Offof Assets | $1,143,000 | $95,000 | $34,000 | $326,000 |
| Amortization Of Securities | $351,000 | $-1,024,000 | $-2,295,000 | $-662,000 |
| Depreciation Amortization Depletion | $3,252,000 | $3,362,000 | $3,105,000 | $2,837,000 |
| Depreciation And Amortization | $3,252,000 | $3,362,000 | $3,105,000 | $2,837,000 |
| Net Income From Continuing Operations | $-47,123,000 | $-46,889,000 | $-52,467,000 | $-60,806,000 |
| Gain Loss On Sale Of PPE | - | - | $0 | $28,000 |
| Sale Of PPE | - | - | - | $0 |
| Gain Loss On Investment Securities | - | - | - | - |
Fetched: 2026-06-17